SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : 2015 Biotech Charity Contest

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: BulbaMan who wrote (339)9/25/2015 5:45:44 PM
From: BulbaMan2 Recommendations

Recommended By
Arthur Radley
rkrw

  Read Replies (3) of 407
 
9/25/15 Contest update
Jumping out from the voluminous barrage of emails I get daily, this caught my eye:
“Republican presidential candidate and retired neurosurgeon Ben Carson said in a 2011 speech that he thought scientist Charles Darwin was ‘encouraged by the adversary,’ using another word for Satan, when he came up with the theory of evolution.”
Here’s the link: talkingpointsmemo.com
Carson’s intriguing surmise prompted me to wonder whether Martin Shkreli was “encouraged by the adversary,” to raise Daraprim’s price from $13.50 to $750. Biotech investors might well have come to such conclusion, as they watched their portfolios pilloried with biblical vengeance in retribution for the sins of Shkreli.
At Friday’s close the Contest median was up a mere 8.95% YTD (vs. up 30.51% YTD a week ago), the Nasdaq Biotech Index was up 2.16% YTD (vs. up 17.47% YTD a week ago), while the smaller-cap S&P Biotechnology Select Industry Index was up 8.67% YTD (vs. up 27.98% YTD a week ago). The Nasdaq Composite Index was down -1.05% YTD (vs. up 1.93% YTD a week ago).
Although significantly humbled this week, DANIEL’S portfolio, up 69.50% YTD, held on to first place. MOPGCW’s portfolio, up 65.50% YTD remained in second place while DONS’ portfolio, up 49.88% YTD, moved to third place.
When the week’s biotech break down ended at the closing bell, 37 of the 51 Contest portfolios were in the green with 37 also beating the NBI and 26 beating the SPSIBI. The 206 Contest stock picks now have an average YTD gain of just 5.88% and a median YTD loss of -6.94%.
Below is the Top Ten list. Also below are the week’s Top 5 & Bottom 5 Stocks. (Foreign stock prices are not converted to US$ in these Tables.)
Portfolio adjustments: None
(All corrections, especially adjustments for buyouts & splits, greatly appreciated.)
Have a relaxing weekend biotechies!
Peace & good health,
Bulba

			9/25/15	
Rank Name Profit/Loss
1 DANIEL 69,496
2 MOPGCW 65,498
3 DONS 49,884
4 DEWDIL 48,847
5 GUERL 48,221
6 MCBIO 40,577
7 GHMM 38,187
8 OLIVIER 33,644
9 JACKH 30,021
10 BAGEL 29,416

Week's Top 5 Gainers
Symbol 9/18/15 9/25/15 Wk.%chg.
PMN.TO 0.070 0.090 28.57%
NRI.TO 6.320 7.160 13.29%
CNAT 4.640 5.160 11.21%
VTL 4.040 4.400 8.91%
ARQL 1.880 2.000 6.38%

Week's Worst 5 Losers
Symbol 9/18/15 9/25/15 Wk.%chg.
IMDZ 18.870 12.950 -31.37%
GTXI 1.200 0.845 -29.58%
BLUE 141.140 100.210 -29.00%
IMGN 14.650 10.440 -28.74%
SRNE 13.010 9.290 -28.59%
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext